MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 40 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $457,000 | – | 45,420 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,921,118 | $38,269,000 | 6.42% |
| FRAZIER MANAGEMENT LLC | 3,566,912 | $71,053,000 | 5.68% |
| Novo Holdings A/S | 2,445,147 | $48,707,000 | 2.52% |
| Sio Capital Management, LLC | 248,978 | $4,960,000 | 1.58% |
| Mesirow Financial Investment Management, Inc. | 25,795 | $514,000 | 1.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,282,912 | $65,396,000 | 1.28% |
| NEA Management Company, LLC | 4,187,801 | $83,421,000 | 0.99% |
| MPM BioImpact LLC | 308,532 | $6,146,000 | 0.95% |
| Rock Springs Capital Management LP | 1,525,623 | $30,390,000 | 0.64% |
| BVF INC/IL | 435,936 | $8,684,000 | 0.34% |